Connect Biopharma Holdings Limited (CNTB) Financials

CNTB Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 43.5 million 16.6 million
March 31, 2026 60.1 million 17.4 million
Dec. 31, 2025 56.1 million 14.1 million
Sept. 30, 2025 67.4 million 12.0 million

CNTB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -20.7 million 1.5 million
March 31, 2026 -16.0 million 1.2 million
Dec. 31, 2025 -11.3 million 917000
Sept. 30, 2025 -17.4 million 916000

CNTB Net Income

No data available :(

CNTB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 31.5 million - 596000
March 31, 2026 - - 693000
Dec. 31, 2025 44.3 million - 690000
Sept. 30, 2025 - - 781000

CNTB Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 62.9 million
March 31, 2026 62.7 million
Dec. 31, 2025 55.7 million
Sept. 30, 2025 55.8 million

CNTB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 16000 16.3 million 4.1 million -
March 31, 2026 - 15.0 million 4.7 million -
Dec. 31, 2025 16000 11.3 million 4.2 million -
Sept. 30, 2025 34000 11.1 million 6.6 million -

CNTB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 2.9 million -
March 31, 2026 169000 -
Dec. 31, 2025 16000 -
Sept. 30, 2025 16000 -

CNTB Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CNTB

Price: $2.04

52 week price:
1.23
3.82

Earnings Per Share: -1.19 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 32100

Market Capitalization: 115.9 million

Links: